🇺🇸 FDA
Patent

US 8916693

Monoconjugated chitosans as delivery agents for small interfering nucleic acids

granted A61KA61K47/549A61K47/60

Quick answer

US patent 8916693 (Monoconjugated chitosans as delivery agents for small interfering nucleic acids) held by Nektar Therapeutics expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K47/549, A61K47/60